Clinical trial
A Parallel-Group Comparison of Two Doses Of Multihance (0.10 mmol/Kg and 0.05 mmol/Kg) When Used For Magnetic Resonance Imaging (MRI) of The Central Nervous System (CNS)
NCT03147989 is registered in ClinicalTrials.gov with Bracco Diagnostics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Parallel-Group Comparison of Two Doses Of Multihance (0.10 mmol/Kg and 0.05 mmol/Kg) When Used For Magnetic Resonance Imaging (MRI) of The Central Nervous System (CNS)
- Lead sponsor
- Bracco Diagnostics, Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 18, 2017
- Completion date
- March 16, 2018
- Enrollment
- 352 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.